Clinical Trials Unit
Stanford University School of Medicine's Center for Advanced Dermatologic Investigation is the Dermatology Department's clinical trials unit.
The Center is home to 12-15 ongoing clinical studies, investigating the safety and efficacy of new and currently available drugs and over-the-counter medications. The Center works with Stanford's own panel on medical research, leading pharmaceutical companies,and the Food and Drug Administration to safely and ethically expand the medical field's knowledge of dermatologic treatments. New studies begin regularly, and the Center continues to recruit patients with skin aging, sun damage, skin cancer (including basal cell carcinomas), psoriasis, atopic dermatitis, rosacea, and other dermatologic diseases for ongoing studies.
Skin Aging Studies
We seek to understand the human aging processes as it relates to skin on a fundamental level. To this end, our studies focus on clinical and translational research efforts ranging from: (1) the analysis of gene changes which predispose individuals to exceptionally youthful skin to (2) molecular signatures that may be biomarkers for aging skin to (3) the careful study of new candidate agents which might affect the skin aging process.
Nonmelanoma Skin Cancer
Recent advances in our understanding of basal cell skin cancer biology have enabled the development of cutting edge study drugs which combat tumor growth. We are currently home to a number of clinical trials at the forefront of potential therapy for advanced or metastatic basal cell cancer. In addition, we seek to understand the biology of basal cell skin cancers and to identify molecular predictors for treatment success.
Acne Rosecea
This is a common and frustrating chronic inflammatory condition of the face, usually affecting older individuals. The causes of this complex condition are the subject of much study. Our clinical studies seek to identify new topical or oral medications to improve the symptoms of acne rosacea.
Contact
For more information, please email dermtrials@stanford.edu
Featured Clinical Trials
Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients
This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine.
Target population: medically stable adolescent solid organ (e.g., heart, kidney, liver, lung, small bowel) transplant recipients and their parent(s)/guardian.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: Assessment of adherence, mental health, behavioral, quality of life and biological constructs
Eligibility
Inclusion Criteria:
The patient:
- and/or their parent(s)/guardian must be able to understand and provide informed
consent in English or Spanish;
- is prescribed tacrolimus (either brand or generic formulation); and
- has been seen in the enrolling center's clinic at least twice in the last two years.
Exclusion Criteria:
The patient:
- received a transplant less than 18 months prior to enrollment;
- has had more than one transplant (including marrow replacement);
- or their parent(s)/guardian is actively psychotic or severely disoriented due to any
cause, including hepatic encephalopathy (temporary exclusion);
- or their parent(s)/guardian has been diagnosed with severe intellectual disability as
defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition
(DSM-5);
- is not medically stable or is hospitalized;
- is currently enrolled in a study that aims to improve adherence to medical
recommendations;
- is receiving cognitive behavioral therapy for confirmed or suspected diagnosis of
Post-Traumatic Stress Disorder (PTSD) at enrollment;
- is receiving psychotropic medications for a confirmed or suspected diagnosis of PTSD.
Ages Eligible for Study
12 Years - 17 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Gioia Zucchero
6504985689
I'm interested
Psoriasis Clinical Trials
Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients
This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine.
Target population: medically stable adolescent solid organ (e.g., heart, kidney, liver, lung, small bowel) transplant recipients and their parent(s)/guardian.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: Assessment of adherence, mental health, behavioral, quality of life and biological constructs
Eligibility
Inclusion Criteria:
The patient:
- and/or their parent(s)/guardian must be able to understand and provide informed
consent in English or Spanish;
- is prescribed tacrolimus (either brand or generic formulation); and
- has been seen in the enrolling center's clinic at least twice in the last two years.
Exclusion Criteria:
The patient:
- received a transplant less than 18 months prior to enrollment;
- has had more than one transplant (including marrow replacement);
- or their parent(s)/guardian is actively psychotic or severely disoriented due to any
cause, including hepatic encephalopathy (temporary exclusion);
- or their parent(s)/guardian has been diagnosed with severe intellectual disability as
defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition
(DSM-5);
- is not medically stable or is hospitalized;
- is currently enrolled in a study that aims to improve adherence to medical
recommendations;
- is receiving cognitive behavioral therapy for confirmed or suspected diagnosis of
Post-Traumatic Stress Disorder (PTSD) at enrollment;
- is receiving psychotropic medications for a confirmed or suspected diagnosis of PTSD.
Ages Eligible for Study
12 Years - 17 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Gioia Zucchero
6504985689
I'm interested
Dermatology Clinical Trials
Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients
This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine.
Target population: medically stable adolescent solid organ (e.g., heart, kidney, liver, lung, small bowel) transplant recipients and their parent(s)/guardian.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: Assessment of adherence, mental health, behavioral, quality of life and biological constructs
Eligibility
Inclusion Criteria:
The patient:
- and/or their parent(s)/guardian must be able to understand and provide informed
consent in English or Spanish;
- is prescribed tacrolimus (either brand or generic formulation); and
- has been seen in the enrolling center's clinic at least twice in the last two years.
Exclusion Criteria:
The patient:
- received a transplant less than 18 months prior to enrollment;
- has had more than one transplant (including marrow replacement);
- or their parent(s)/guardian is actively psychotic or severely disoriented due to any
cause, including hepatic encephalopathy (temporary exclusion);
- or their parent(s)/guardian has been diagnosed with severe intellectual disability as
defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition
(DSM-5);
- is not medically stable or is hospitalized;
- is currently enrolled in a study that aims to improve adherence to medical
recommendations;
- is receiving cognitive behavioral therapy for confirmed or suspected diagnosis of
Post-Traumatic Stress Disorder (PTSD) at enrollment;
- is receiving psychotropic medications for a confirmed or suspected diagnosis of PTSD.
Ages Eligible for Study
12 Years - 17 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Gioia Zucchero
6504985689
I'm interested
Pediatric Dermatology Clinical Trials
Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients
This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine.
Target population: medically stable adolescent solid organ (e.g., heart, kidney, liver, lung, small bowel) transplant recipients and their parent(s)/guardian.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: Assessment of adherence, mental health, behavioral, quality of life and biological constructs
Eligibility
Inclusion Criteria:
The patient:
- and/or their parent(s)/guardian must be able to understand and provide informed
consent in English or Spanish;
- is prescribed tacrolimus (either brand or generic formulation); and
- has been seen in the enrolling center's clinic at least twice in the last two years.
Exclusion Criteria:
The patient:
- received a transplant less than 18 months prior to enrollment;
- has had more than one transplant (including marrow replacement);
- or their parent(s)/guardian is actively psychotic or severely disoriented due to any
cause, including hepatic encephalopathy (temporary exclusion);
- or their parent(s)/guardian has been diagnosed with severe intellectual disability as
defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition
(DSM-5);
- is not medically stable or is hospitalized;
- is currently enrolled in a study that aims to improve adherence to medical
recommendations;
- is receiving cognitive behavioral therapy for confirmed or suspected diagnosis of
Post-Traumatic Stress Disorder (PTSD) at enrollment;
- is receiving psychotropic medications for a confirmed or suspected diagnosis of PTSD.
Ages Eligible for Study
12 Years - 17 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Gioia Zucchero
6504985689
I'm interested
Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients
This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine.
Target population: medically stable adolescent solid organ (e.g., heart, kidney, liver, lung, small bowel) transplant recipients and their parent(s)/guardian.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: Assessment of adherence, mental health, behavioral, quality of life and biological constructs
Eligibility
Inclusion Criteria:
The patient:
- and/or their parent(s)/guardian must be able to understand and provide informed
consent in English or Spanish;
- is prescribed tacrolimus (either brand or generic formulation); and
- has been seen in the enrolling center's clinic at least twice in the last two years.
Exclusion Criteria:
The patient:
- received a transplant less than 18 months prior to enrollment;
- has had more than one transplant (including marrow replacement);
- or their parent(s)/guardian is actively psychotic or severely disoriented due to any
cause, including hepatic encephalopathy (temporary exclusion);
- or their parent(s)/guardian has been diagnosed with severe intellectual disability as
defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition
(DSM-5);
- is not medically stable or is hospitalized;
- is currently enrolled in a study that aims to improve adherence to medical
recommendations;
- is receiving cognitive behavioral therapy for confirmed or suspected diagnosis of
Post-Traumatic Stress Disorder (PTSD) at enrollment;
- is receiving psychotropic medications for a confirmed or suspected diagnosis of PTSD.
Ages Eligible for Study
12 Years - 17 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Gioia Zucchero
6504985689
I'm interested
Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients
This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine.
Target population: medically stable adolescent solid organ (e.g., heart, kidney, liver, lung, small bowel) transplant recipients and their parent(s)/guardian.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: Assessment of adherence, mental health, behavioral, quality of life and biological constructs
Eligibility
Inclusion Criteria:
The patient:
- and/or their parent(s)/guardian must be able to understand and provide informed
consent in English or Spanish;
- is prescribed tacrolimus (either brand or generic formulation); and
- has been seen in the enrolling center's clinic at least twice in the last two years.
Exclusion Criteria:
The patient:
- received a transplant less than 18 months prior to enrollment;
- has had more than one transplant (including marrow replacement);
- or their parent(s)/guardian is actively psychotic or severely disoriented due to any
cause, including hepatic encephalopathy (temporary exclusion);
- or their parent(s)/guardian has been diagnosed with severe intellectual disability as
defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition
(DSM-5);
- is not medically stable or is hospitalized;
- is currently enrolled in a study that aims to improve adherence to medical
recommendations;
- is receiving cognitive behavioral therapy for confirmed or suspected diagnosis of
Post-Traumatic Stress Disorder (PTSD) at enrollment;
- is receiving psychotropic medications for a confirmed or suspected diagnosis of PTSD.
Ages Eligible for Study
12 Years - 17 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Gioia Zucchero
6504985689
I'm interested